Andrew McLean

4f8ffaf7-d7de-4d26-b08b-7f48272fb905-cropped
Principal Investor

Andrew McLean is the lead life sciences investor for Oxford Sciences Innovation. OSI is a £350 million company investing in the most exciting start-ups built on world-leading Oxford science. Prior to joining OSI Andrew consulted in the pharmaceutical & biotech practice at McKinsey. Andrew is a physician by training, studied philosophy, politics & economics at Christ Church in Oxford and his work background includes stints in wine shops, hospitals & Goldman Sachs.

Being LGBT in Finance
22nd October 2016
16:00  -  17:00